A 59-year-old housewife, a non-smoker, had been maintained for some years with salbutamol and beclomethasone aerosols for her asthma. She was admitted to hospital with a seven-day history of progressively worsening dyspnoea associated with marked wheezing, unrelieved by more frequent use of her inhalers, the addition of prednisolone (40 mg daily), and a dose of intravenous hydrocortisone (100 mg) given on the day of admission. There had been no fever, sputum, or any infective illness before her acute symptoms.
On examination she appeared mildly dehydrated and was severely dyspnoeic with poor chest expansion, reduced breath sounds, and widespread expiratory wheeze. Blood pressure was 140/90 with 20 mm Hg of paradox, and a sinus tachycardia of 120. Chest radiology revealed marked hyperinflation but no pneumothorax or infective changes. Blood gases on air demonstrated a Po2 of 61 mm Hg (8 kPa), a Pco2 of 54mm Hg (7-2 kPa), and a pH of 7-34. Other investigations included a haemoglobin of 13-0 g/dl, white cell count of 10 000/mm3, sodium of 130 mmol/l, potassium of 4-1 mmol/l, and urea of 6-2 mmol/l.
The initial therapy included an infusion of hydrocortisone (2 g/24 hours in 2 litres of 5 % dextrose), bolus doses of salbutamol (500 jig six hourly), nebulised salbutamol (5 mg four hourly), and oral prednisolone (40 mg/24 hours). Potassium supplements were given intravenously and orally at a rate of 86 mmol/24 hours.
Despite a transient improvement her peak flows remained at 50 I/min and over the next 72 hours she became progressively more confused and lethargic. A fluid intake of 2 5-3-0 litres daily did not increase the urine output above 700 ml/24 hours, and she was found to have developed sacral and ankle oedema. The sodium had fallen to 110 mmol/l and the serum osmolality was 228 mOsm/kg (normal range 270-295 mOsm/kg) with a urine osmolality of 836 mOsm/kg. The potassium had risen to 6-0 mmol/l and the urine electrolytes revealed a sodium of 11 mmol/l, potassium of 120 mmol/l. The changes are illustrated in the figure.
The potassium supplements and intravenous salbutamol were stopped and fluid intake was restricted to 750 ml/ 24 hours. Seventy-two hours later the serum osmolality had risen to 270 mOsm/l, the sodium to 128 mmol/l, and the potassium had fallen to 3-5 mmol/l. In parallel with these electrolyte changes the patient became fully rational and orientated. However when the fluid intake was increased to 1-0-15 litres the serum osmolality fell to 260 mOsm/kg and the sodium remined at 128 mmol/l, a return to normal values of these measurements taking a further seven days with fluid restricted to less than 10 litre/24 hours. Eleven days after the start of fluid restriction the patient was able to take fluids freely with no further electrolyte changes.
During this period the patient's Po2 rose to 80 mm Hg.
(11 kPa) and her peak flow rate increased to 250 litres/ min, these figures representing the best obtainable.
Discussion
The clinical syndrome of inappropriate ADH secretion comprises dilutional hyponatraemia, a low serum osmolality with a paradoxically raised urine osmolality and, when measured, raised ADH levels in serum. These biochemical features account for the common signs of lethargy, confusion, coma, and convulsions. One study exists of patients with status asthmaticus who exhibited raised levels of ADH. 
